This project will analyze various methods for performing antimicrobial susceptibility tests of Mycobacterium avium complex (MAC), with the goal of determining which test method correlates best with clinical response in the patient. Such a study is needed because little information exists relating in the in vitro activity of drugs with clinical response to drug treatment, and because there are a number of different methods for performing drug susceptibility tests against MAC, each giving different data and each with its own advantages and disadvantages. The methods that will be compared in this study include measurements of the activity of drugs i) in broth medium, ii) inside a mouse macrophage-derived cell line (J774), and iii) inside alveolar macrophages obtained from HIV-infected patients. The MAC strains to be used in these experiments are strains isolated from patients enrolled in ACTG protocol 135, a clinical trial comparing a 4-drug versus a 5-drug regimen for treatment of disseminated MAC infection. Susceptibility tests will be performed using common broth culture techniques to measure survival of MAC after exposure to each of the single drugs and to the 4-drug and 5-drug combinations used in treatment of patients in ACTG 135. In addition, mouse J774 cells and alveolar macrophages from HIV-infected patients will be infected with these MAC strains then treated with the same antimicrobial agents, using both single drugs and drug combinations. Survival of MAC inside drug-tested cells and control (untreated) cells will be followed over time. A major objective of this study will be to determine under what conditions the simpler broth and J-cell methods can be used to reliably assess the in vitro activity of drugs against MAC. This will be accomplished by comparing the quantitative data obtained from the three in vitro methods will clinical data obtained in ACTG 135. The results of these experiments will provide the most complete set of data to date on the relationship between in vitro MAC susceptibility test results and clinical response to treatment. The results will also aid in the development of standardized methods for performing drug susceptibility against MAC.

Project Start
1999-01-01
Project End
1999-12-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
13
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Kempen, John H; Sugar, Elizabeth A; Varma, Rohit et al. (2014) Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infections. Ophthalmology 121:2317-24
Kozak, Igor; Vaidya, Vijay; Van Natta, Mark L et al. (2014) The prevalence and incidence of epiretinal membranes in eyes with inactive extramacular CMV retinitis. Invest Ophthalmol Vis Sci 55:4304-12
Amorosa, Valerianna K; Luetkemeyer, Anne; Kang, Minhee et al. (2013) Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial. HIV Clin Trials 14:274-83
Jabs, Douglas A; Ahuja, Alka; Van Natta, Mark et al. (2013) Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology 120:1262-70
Gangaputra, Sapna; Drye, Lea; Vaidya, Vijay et al. (2013) Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 155:206-212.e5
Kempen, John H; Sugar, Elizabeth A; Lyon, Alice T et al. (2012) Risk of cataract in persons with cytomegalovirus retinitis and the acquired immune deficiency syndrome. Ophthalmology 119:2343-50
Gangaputra, Sapna; Kalyani, Partho S; Fawzi, Amani A et al. (2012) Retinal vessel caliber among people with acquired immunodeficiency syndrome: relationships with disease-associated factors and mortality. Am J Ophthalmol 153:434-444.e1
Kalyani, Partho S; Fawzi, Amani A; Gangaputra, Sapna et al. (2012) Retinal vessel caliber among people with acquired immunodeficiency syndrome: relationships with visual function. Am J Ophthalmol 153:428-433.e1
Sezgin, Efe; van Natta, Mark L; Ahuja, Alka et al. (2011) Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus. Am J Ophthalmol 151:999-1006.e4
Puhan, Milo A; Ahuja, Alka; Van Natta, Mark L et al. (2011) Interviewer versus self-administered health-related quality of life questionnaires - does it matter? Health Qual Life Outcomes 9:30

Showing the most recent 10 out of 82 publications